FDA UPDATES OPIOID LABEL TO PROMOTE SAFER USE
The Food and Drug Administration (“FDA”) has new labeling requirements for extended-release and long-acting (“ER/LA”)
NO FEE UNLESS WE WIN
FREE CASE REVIEW
800-247-1623
The Food and Drug Administration (“FDA”) has new labeling requirements for extended-release and long-acting (“ER/LA”)
In July, 2011, the US Food and Drug Administration (FDA) issued a proposal for guidelines
Data from 2011 reveals that pedestrian fatalities have increased while total traffic fatalities decreased. Pedestrian
In October 2013, the U.S. Department of Transportation’s Federal Motor Carrier Safety Administration (FMCSA) issued
On October 8, 2013, Bloomberg published an article regarding the potential risks associated with robot-assisted
A recent study conducted by the Texas A&M Transportation Institute shows that while fatal crash
Summary On October 7, 2013, the Fort Worth Star-Telegram published an article regarding the serious
The first DePuy ASR bellwether trial in the consolidated California state court litigation was scheduled
The Headquarters Marine Corps Exchange buyer has notified Camp Pendleton exchanges to ban the sale
The United States Air Force has issued a warning to service men and women regarding
The Huffington Post has reported that a forty-eight year old mother of seven has died
A recent study sponsored by the Southwest Region University Transportation Center and conducted by the
Get a Free Consultation. No Fees Unless We Win. We’re Here 24/7